Antimicrobial peptides (AMPs) are considered an important first line of defense against pathogens. Cathelicidin LL-37 was upregulated in response to fungal infection. In this work we aimed to evaluate cathelicidin LL-37 in the hair of tinea capitis and compare it to normal controls. Hair samples were collected from 30 children and 30 controls aged from 2 to10 years old, and the level of cathelicidin LL-37 in the hair was detected by quantitative real-time PCR. The 30 patients were further subdivided into three subgroups according to their clinical type. Ten patients were scaly type, 10 patients were black dots type, and 10 patients were kerion type. Cathelicidin level in patients ranged from 6.0 to 17.5 with mean ± SD (11.3 ± 2.3) and in control ranged from 1.02 to 6.2, with mean ± SD (2.8 ± 1.5). There was a significant difference between the patients and controls regarding the cathelicidin level; P value was 0. The mean cathelicidin level was lowest in the kerion type10.73 ± 2.6 and highest in the black dot type 12.05 ± 2.76. However, there was no significant difference between the cathelicidin level of the different clinical types of tinea capitis; P value was 0.58. In conclusion, the level of cathelicidin LL-37 in hair specimens of human tinea capitis was significantly higher than controls.
Introduction
Tinea capitis is a dermatophyte infection of the scalp occurring predominantly in children. The causative organisms belong to Microsporum and Trichophyton. 1, 2 The clinical spectrum ranged from noninflammatory in the anthrophilic types to severe inflammatory in the zoophilic types. 2 The noninflammatory result in black dot and scaly clinical pictures while the inflammatory result in favus and kerion clinical pictures.
and fungi. 5, 6 AMPs produced in human skin included defensins, cathelicidins, dermcidin, and other short proteins. 5, 6 In the skin cathelicidin LL-37 is produced by epithelial cells and by infiltrating immune cells such as neutrophils then stored in lamellar bodies. 7 Moreover, cathelicidin LL-37 is produced by the eccrine apparatus and secreted in the sweat. 8 The cathelicidin LL-37 was upregulated in response to fungal infection of the nasal tissue. 9 Cathelicidin LL-37 showed antifungal activity against Malassezia furfur, Epidermophyton, and Microsporum, the causative agents of tinea versicolor and tinea corporis. 10 Moreover, cathelicidin showed antifungal activity against candida. [11] [12] [13] In this work we aimed to compare the cathelicidin LL-37 in tinea capitis and normal controls.
Patients and methods
Thirty children aged 2-10 years who fulfilled the clinical and microscopic criteria of tinea capitis participated in this study. The diagnosis was confirmed clinically and using Wood's light examination, direct microscopic examination with KOH 20%, and fungal culture. Thirty healthy individuals served as controls. Patients taking any systemic or dermatological treatments were excluded from this study. This study was approved by the ethical committee of the dermatology department and was conducted according to the declaration of Helsinki principles. Informed consents were obtained from the parents of the children.
Hair samples were collected from the patients and controls by plucking. The hair was collected from the affected area of the patient. Cathelicidin level in the hair collected from patients and controls; was detected by quantitative real-time polymerase chain reaction (RT-PCR) according to Pfaffl, 2001. 14 Total RNA was extracted from hair using SV total RNA isolation system (Promega, Madison, WI, USA). About 30 mg of hair were homogenized in 175 μl of lysis buffer; 350 μl of SV RNA dilution buffer was added to 175 μl of hair homogenate. The extracted RNA was reverse transcribed into cDNA using RT-PCR kit (Stratagene, USA). The sequence of the Cathelicidin LL-37 primers were: F-CCAGGACGACACAGCAGTCA, R-CTTCACCAGCCCGTCCTTC. At the end of qPCR running with SYBR green chemistry, the relative quantification was used according to applied biosystem software reference. 14 
Statistical analysis
All data obtained were transferred to the statistical package SPSS (statistical package for social science) version 13 for 
Results
Thirty patients and 30 controls participated in this study. The patients were further subdivided into three subgroups according to their clinical type. Ten patients were scaly type, 10 patients were black dots type, and 10 patients were kerion type. The demographic data of the patients and controls was summarized in Table 1 . The organisms that were detected were Microsporum canis, Trichophyton violaceum, and Trichophyton verrucosum. There was significant difference between patients and controls regarding the contact to domestic animals; P value was 0 ( Table 1) . The animals that were involved were dogs and cattle.
Cathelicidin level in patients ranged from 6.0 to 17.5 with mean ± SD (11.3 ± 2.3) and in control ranged from 1.02 to 6.2, with mean ± SD (2.8 ± 1.5) (Table 2). There was a significant difference between the patients and controls regarding the cathelicidin level; P value was 0.
The mean cathelicidin level was lowest in the kerion type (10.73 ± 2.6) and highest in the black dot type (12.05 ± 2.76). However, there was no significant difference between the cathelicidin level of the different clinical types of tinea capitis; P value was 0.58 (Table 3) . There was weak significant positive correlation between the age of the child and the cathelicidin level (Table 4) . There was no significant correlation between cathelicidin level and the disease duration, number, size of lesions, body mass index of the patients with tinea capitis.
Discussion
The innate host defense mechanism against the fungi are mediated by various mechanisms; for example, sebum factors such as medium chain fatty acids inhibit dermatophyte growth, 15 neutrophils and macrophages exert fungicidal activity 16 and AMPs. Lopez-Garcia et al. reported an increase in LL-37 expression in epidermis of tinea corporis and tinea versicolor compared to healthy skin. 10 The current study adds that there is significantly high cathelicidin level in the hair of tinea capitis in comparison with healthy controls. LL-37 exerts microbicial effects through several mechanisms. In addition to its direct microbicidal effect, it is chemotactic to neutrophils, it inhibits neutrophil apoptosis, and it enhances the production of reactive oxygen species. 17 Our results showed significant difference between patients and controls regarding the contact with domestic animals. Animals are an important method of spread of infections to humans. Zoophilic infections are often characterized by pronounced inflammatory reaction in comparison to the anthropophilic ones. 2 Our results showed positive correlation between cathelicidin level and the age of children. This suggests that as the child grows his cathelicidin level increases to combat infections. This agrees with Stukes et al. who showed that the level of circulatory cathelicidins increase with the age of children. 18 Contrary to Stukes et al., our results did not show significant gender differences in the cathelicidin levels between males and females. Our results did not show statistical significant differences in the cathelicidin levels of different types of tinea capitis. This could be due to the small sample size in each type. However, the mean cathelicidin level was lowest in the kerion (inflammatory type) and highest in black dot (noninflammatory type). Although cathelicidins is involved mainly in innate immunity, studies showed that they modulate adaptive immunity. 19 The difference of cathelicidin level in the inflammatory and the noninflammatory types of tinea capitis can be explained by the difference between cell mediated and humoral immunity.
Limitations of this study included the small sample size in each type of tinea capitis and that we did not measure the protein levels.
In conclusion, the level of cathelicidin LL-37 in hair specimens of human tinea capitis was significantly higher than controls. This suggests that cathelicidins play a role in the defence against tinea capitis. New therapeutic modalities targeting LL-37 might be efficient to treat tinea capitis with less side effects.
